Back to search

Article

Effects of Metformin on Transcriptomic and Metabolomic Profiles in Breast Cancer Survivors Enrolled in the Randomized Placebo-Controlled MetBreCS Trial

2023-10-19

Abstract excerpt

<h4>Background: </h4> Metformin reduces the incidence of breast cancer in patients with type 2 diabetes and obesity. However, our knowledge about the effects of metformin on cancer recurrence in breast tissue is limited. Therefore, in this study, we examined the breast tissue gene expression changes by metformin in breast cancer survivors. <h4>Methods: </h4> Within the randomized placebo-controlled MetBreCS trial,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9a46ea1e-0469-57c1-8c07-e6f0bb3c3905
DOI
10.21203/rs.3.rs-3404464/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effects of Metformin on Transcriptomic and Metabolomic Profiles in Breast Cancer Survivors Enrolled in the Randomized Placebo-Controlled MetBreCS TrialDOI 10.21203/rs.3.rs-3404464/v1
Select a neighboring publication to make it the new centre.